| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |